相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Frequent Large Germline HRPT2 Deletions in a French National Cohort of Patients With Primary Hyperparathyroidism
Leopoldine Bricaire et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer
Filomena Cetani et al.
ENDOCRINE CONNECTIONS (2013)
Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma
Hee Kyung Kim et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
Novel HRPT2/CDC73 Gene Mutations and Loss of Expression of Parafibromin in Chinese Patients with Clinically Sporadic Parathyroid Carcinomas
Ou Wang et al.
PLOS ONE (2012)
CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort
Vito Guarnieri et al.
CELLULAR ONCOLOGY (2012)
Parathyroid carcinoma: increasing incidence and changing presentation
Sebastian Brown et al.
ANZ JOURNAL OF SURGERY (2011)
Metastatic parathyroid carcinoma initially misdiagnosed as parathyroid adenoma: the role of parafibromin in increasing diagnostic accuracy
S. Lim et al.
INTERNAL MEDICINE JOURNAL (2011)
Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma
Janneke E. Witteveen et al.
MODERN PATHOLOGY (2011)
Parafibromin and APC as Screening Markers for Malignant Potential in Atypical Parathyroid Adenomas
C. Christofer Juhlin et al.
ENDOCRINE PATHOLOGY (2010)
Accuracy of Combined Protein Gene Product 9.5 and Parafibromin Markers for Immunohistochemical Diagnosis of Parathyroid Carcinoma
Viive M. Howell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Familial hyperparathyroidism:: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations
Marta S. Sarquis et al.
SURGERY (2008)
Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma
G. Y. Meyer-Rochow et al.
BRITISH JOURNAL OF SURGERY (2007)
Parafibromin immunoreactivity:: its use as an additional diagnostic marker for parathyroid tumor classification
C. C. Juhlin et al.
ENDOCRINE-RELATED CANCER (2007)
Trends in the incidence and treatment of parathyroid cancer in the United States
Peter K. Lee et al.
CANCER (2007)
Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma
G. Ippolito et al.
BRITISH JOURNAL OF SURGERY (2007)
Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?
Filomena Cetani et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
HRPT2 mutational analysis of typical sporadic parathyroid adenomas
LJ Krebs et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Genetic analyses of the HRPT2 gene in primary hyperparathyroidism:: Germline and somatic mutations in familial and sporadic parathyroid tumors
F Cetani et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma
MH Tan et al.
CLINICAL CANCER RESEARCH (2004)
Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma
TM Shattuck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
VM Howell et al.
JOURNAL OF MEDICAL GENETICS (2003)
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome
JD Carpten et al.
NATURE GENETICS (2002)
分享论文
